LSLihua Song

Lihua Song

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lihua Song has a total of 214 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A nucleocapsid-tagged fluorescent pangolin coronavirus enables authentic-virus neutralization assays and localizes the antiviral activity of cepharanthine to viral entry

    by Yuezhen Ma, Shanshan Lu, Shengdong Luo, Yue Hu, Chenyang Wang, Xiao Zhang, Li Deng, Caiwu Li, Weiwei Chen, Wenxin Zheng, et al.

    Replication-competent coronaviruses carrying a fluorescently tagged structural protein are rare, and the only well-developed example tags the membrane (M) protein. Using the highly attenuated pangolin coronavirus GX_P2V(short_3UTR) as a backbone, we assembled a full-length cDNA clone by multifragment in vitro ligation and recovered GX_P2V-mBJ-N, a recombinant virus in which the bright monomeric green fluorescent protein mBaoJin is fused to the N terminus of the nucleocapsid (N) protein. The equivalent C-terminal fusion was not viable. GX_P2V-mBJ-N is infectious in Vero E6 cells but is attenuated and genetically unstable in the absence of exogenous N; supplying wild-type N in trans allows propagation to high titer with the fusion intact. Because mBaoJin is translated as part of N, fluorescence reports viral antigen synthesis directly, and infection can be quantified in a plate reader without immunostaining or plaque reduction. We applied the reporter virus in two settings. First, sera from ten healthy blood donors were titrated in parallel against GX_P2V-mBJ-N and a vesicular stomatitis virus (VSV)-based GX_P2V pseudovirus. The two assays agreed on rank order, but pseudovirus titers were about 10-fold higher overall and diverged by at least 70-fold in one donor, showing that the two formats are not interchangeable for individual samples. Second, time-of-addition experiments identified entry as the principal target of cepharanthine (EC50, 0.20 μM under continuous treatment), whereas preincubation of virions with 25 μM drug had no effect, excluding direct virion inactivation. GX_P2V-mBJ-N provides a practical authentic-virus platform for coronavirus serology and antiviral pharmacology.

  • Open Access

    An infection and pathogenesis mouse model of SARS‐CoV‐2‐related pangolin coronavirus GX_P2V(short_3UTR)

    by Lai Wei, Shuiqing Liu, Shanshan Lu, Shengdong Luo, Xiaoping An, Huahao Fan, Erguang Li, Lihua Song

    Impact statement: SARS‐CoV‐2‐related pangolin coronavirus GX_P2V(short_3UTR) is highly attenuated, but can cause mortality in a specifically designed human ACE2 ‐transgenic mouse model, making it a surrogate model for evaluating the efficacy of vaccines and drugs against SARS‐CoV‐2.


  • Open Access

    An MDR Salmonella Enteritidis sublineage associated with gastroenteritis outbreaks and invasive disease in China

    by Xiaoyi Zheng, Ying Xiang, Xiaoying Li, Xinying Du, Yule Wang, Sai Tian, Jingzhuang Xue, Ying Huang, Hongbo Liu, Qi Wang, et al.


  • Open Access

    Methylene Blue Has Strong Extracellular Virucidal Activity Against a SARS-CoV-2-Related Pangolin Coronavirus with No Intracellular or In Vivo Efficacy

    by Lai Wei, Yuezhen Ma, Yuhao Ren, Shanshan Lu, Xiumei Xiao, Shengdong Luo, Xiaoping An, Erguang Li, Huahao Fan, Lihua Song

    Studies have demonstrated that methylene blue exhibits significant antiviral activity against SARS-CoV-2 or related coronaviruses at the cellular level, suggesting its potential as an anti-SARS-CoV-2 drug. Herein, we report that methylene blue does not exhibit noticeable antiviral activity in a lethal model involving SARS-CoV-2-related pangolin coronavirus GX_P2V (short_3UTR) infection in CAG-hACE2 transgenic mice. We employed plaque reduction assays and cell infection experiments to compare the extracellular virucidal activity of the compound and its ability to inhibit viral replication in cells to those of nirmatrelvir. Methylene blue demonstrated strong virucidal activity but did not inhibit viral replication in cells. The control compound nirmatrelvir lacked virucidal activity but exhibited strong abilities to inhibit viral replication. The virucidal activity of methylene blue was further tested in mouse plasma. Incubation in mouse plasma increased the virucidal EC50 value of methylene blue, indicating that mouse plasma can affect the stability of the compound, although mouse plasma has some extent of natural virucidal activity. These findings elucidate why methylene blue lacks antiviral efficacy in vivo and provide insights for the development of antiviral drugs.


  • Open Access

    A review of Mpox: Biological characteristics, epidemiology, clinical features, diagnosis, treatment, and prevention strategies

    by Lin Jiang, Ailan Xu, Lin Guan, Yong Tang, Guangshuai Chai, Junya Feng, Yueqi Wu, Maochen Li, Chuxie Zhang, Xiaojing Liu, et al.

    The outbreak of monkeypox virus (MPXV) was declared a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO), and the zoonotic disease caused by viral infection was renamed as “Mpox” on November 28, 2022. Currently, there is no approved vaccine or specific antiviral treatment for Mpox, and a main preventive strategy against MPXV infection remains the smallpox vaccine. Although there was an emergency use authorization (EUA) of Brincidofovir and Tecovirimat for the clinical treatment of clade II Mpox, while Tecovirimat failed to reduce the duration of Mpox lesions among patients infected with clade I Mpox in the Democratic Republic of the Congo (DRC). Therefore, it is still an urgent need to develop an effective medication. This review aims to enhance the understanding of Mpox and contribute to its prevention and treatment strategies, it provides a systemic introduction of the biological and epidemiological characteristics of MPXV, the clinical feature and diagnosis of Mpox, as well as treatment and prevention strategies, which will improve the comprehension about MPXV and offer potential strategies for clinical treatment.


  • Open Access

    A Comparative Experimental and Computational Study on the Nature of the Pangolin-CoV and COVID-19 Omicron

    by Lai Wei, Lihua Song, A. Keith Dunker, James A. Foster, Vladimir N. Uversky, Gerard Kian-Meng Goh

    The relationship between pangolin-CoV and SARS-CoV-2 has been a subject of debate. Further evidence of a special relationship between the two viruses can be found by the fact that all known COVID-19 viruses have an abnormally hard outer shell (low M disorder, i.e., low content of intrinsically disordered residues in the membrane (M) protein) that so far has been found in CoVs associated with burrowing animals, such as rabbits and pangolins, in which transmission involves virus remaining in buried feces for a long time. While a hard outer shell is necessary for viral survival, a harder inner shell could also help. For this reason, the N disorder range of pangolin-CoVs, not bat-CoVs, more closely matches that of SARS-CoV-2, especially when Omicron is included. The low N disorder (i.e., low content of intrinsically disordered residues in the nucleocapsid (N) protein), first observed in pangolin-CoV-2017 and later in Omicron, is associated with attenuation according to the Shell-Disorder Model. Our experimental study revealed that pangolin-CoV-2017 and SARS-CoV-2 Omicron (XBB.1.16 subvariant) show similar attenuations with respect to viral growth and plaque formation. Subtle differences have been observed that are consistent with disorder-centric computational analysis.


  • Open Access

    A Comparative Experimental and Computational Study on the Nature of the Pangolin-CoV and COVID-19 Omicron

    by Lai Wei, Lihua Song, A. Keith Dunker, James A. Foster, Vladimir N. Uversky, Gerard Kian-Meng Goh

    The relationship between pangolin-CoV and SARS-CoV-2 has been a subject of debate. Further evidence of a special relationship between the two viruses can be found by the fact that all known COVID-19 viruses have abnormally hard outer shell (low M disorder; i.e., low content of intrinsically disordered residues in the membrane (M) protein) that so far was found in CoVs associated with burrowing animals, such as rabbits and pangolins, in which transmission involves virus remaining in buried feces for a long time. While a hard outer shell is necessary for viral survival, a harder inner shell could also help. For this reason, the N disorder range of pangolin-CoVs, not bat-CoVs, more closely matches that of SARS-CoV-2 especially when Omicron is included. The low N disorder (i.e., low content of intrinsically disordered residues in the nucleocapsid (N) protein), first observed in pangolin-CoV-2017 amd later in Omicron, is associated with attenuation according to the Shell-Disorder-Model. Our experimental study revealed that pangolin-CoV-2017 and SARS-CoV-2 Omicron (XBB.1.16 subvariant) show similar attenuations with respect to viral growth and plaque formation. Subtle differences have been observed that are consistent with disorder-centric computational analysis.


  • Open Access

    An infection and pathogenesis mouse model of SARS-CoV-2-related pangolin coronavirus GX_P2V(short_3UTR)

    by Lai Wei, Shuiqing Liu, Shanshan Lu, Shengdong Luo, Xiaoping An, Huahao Fan, Weiwei Chen, Erguang Li, Yigang Tong, Lihua Song

    SARS-CoV-2-related pangolin coronavirus GX_P2V(short_3UTR) is highly attenuated, but can cause mortality in a specifically designed human ACE2-transgenic mouse model, making it an invaluable surrogate model for evaluating the efficacy of drugs and vaccines against SARS-CoV-2.


  • Open Access

    Genetic and Phenotypic Analysis of Phage-Resistant Mutant Fitness Triggered by Phage–Host Interactions

    by Yanze Mi, Yile He, Jinhui Mi, Yunfei Huang, Huahao Fan, Lihua Song, Xiaoping An, Shan Xu, Mengzhe Li, Yigang Tong

    The emergence of phage-resistant bacterial strains is one of the biggest challenges for phage therapy. However, the emerging phage-resistant bacteria are often accompanied by adaptive trade-offs, which supports a therapeutic strategy called “phage steering”. The key to phage steering is to guide the bacterial population toward an evolutionary direction that is favorable for treatment. Thus, it is important to systematically investigate the impacts of phages targeting different bacterial receptors on the fitness of the bacterial population. Herein, we employed 20 different phages to impose strong evolutionary pressure on the host Pseudomonas aeruginosa PAO1 and examined the genetic and phenotypic responses of their phage-resistant mutants. Among these strains with impaired adsorptions, four types of mutations associated with bacterial receptors were identified, namely, lipopolysaccharides (LPSs), type IV pili (T4Ps), outer membrane proteins (OMPs), and exopolysaccharides (EPSs). PAO1, responding to LPS- and EPS-dependent phage infections, mostly showed significant growth impairment and virulence attenuation. Most mutants with T4P-related mutations exhibited a significant decrease in motility and biofilm formation ability, while the mutants with OMP-related mutations required the lowest fitness cost out of the bacterial populations. Apart from fitness costs, PAO1 strains might lose their resistance to antibiotics when counteracting with phages, such as the presence of large-fragment mutants in this study, which may inspire the usage of phage–antibiotic combination strategies. This work provides methods that leverage the merits of phage resistance relative to obtaining therapeutically beneficial outcomes with respect to phage-steering strategies.


  • Open Access

    A potential broad-spectrum live-attenuated SARS-CoV-2 vaccine derived from pangolin coronavirus and insights into the immune evasion mechanisms of XBB.1.16 variant

    by Lihua Song, Shanshan Lu, Shengdong Luo, Bingke Bai, Liangliang Jiang, Zhenping Fan, Lai Wei, Luyang Hai, Wen Xu, Panyong Mao, et al.

    Harnessing SARS-CoV-2 related viruses from wild animals for live vaccines is an underexplored but promising approach, akin to the vaccinia virus used against smallpox. This study evaluated the potential of a live-attenuated vaccine derived from the pangolin coronavirus GX_P2V. We observed that the attenuated mutant, GX_P2V(short_3UTR), conferred significant and long-lasting protection against SARS-CoV-2 in golden hamsters, particularly after two doses. Furthermore, we show that sera from vaccinated convalescents of SARS-CoV-2 variant XBB.1.16 exhibited high titers of neutralizing antibody against GX_P2V(short_3UTR), suggesting GX_P2V(short_3UTR) shares neutralizing epitopes with XBB.1.16. We also show that the same sera from convalescents of XBB.1.16 displayed significantly reduced titers against the XBB.1.16 variant itself, suggesting a decoy-like immune evasion strategy that high-level cross-neutralizing antibodies induced by highly immunogenic epitopes of XBB.1.16 may not be able to efficiently neutralize the virus itself. Our findings emphasize GX_P2V(short_3UTR)'s potential as a broad-spectrum SARS-CoV-2 live vaccine and shed light on novel immune evasion mechanisms of the XBB.1.16 variant.